CNBC Originals

CNBC’s Melissa Lee investigates the booming cannabis industry, a market expected to hit $83 billion in the U.S. by 2025, thanks in part to marijuana’s new reputation as an all-natural cure for illness, boredom and just about everything in between. While some believe the industry is poised for another round of explosive growth, others are sounding the alarm. CNBC gains unprecedented access to some of pot’s biggest corporate players and explores the burning question: is cannabis the miracle drug that consumers and investors are banking on, or is it the product of misleading marketing by an industry where nothing is quite as it seems?

Andrew Ross Sorkin reports on the life and crimes of Bernie Madoff, one of the most notorious white collar criminals in history.

Go inside one of the most powerful, storied and consequential players in the energy industry: ExxonMobil. Once seen as untouchable, the company is now facing shareholder challenges over its direction and criticism that it fostered public uncertainty about global warming.

CNBC takes an in-depth look at how a new generation of drugs is treating obesity and changing culture in the process. Is this innovation at its best, or is the rush for better weight loss medications out of control?

CNBC’s Disruptor 50 goes inside some of the most disruptive, privately held companies in the world to meet the entrepreneurs who are transforming industries.

Tesla CEO Elon Musk sits down exclusively with CNBC’s David Faber for an in-depth interview about autonomous driving, the future of robotics and DOGE.